Xin Lun, Zhang Zhe, Shah Kushan, Hashemi Venus, Li Xuanyue, Qin Grace, Ren Steven, Chen Wei, Li Yunsong
BioDev Department, WuXi Biologics, 1 Cedarbrook Dr, Cranbury, NJ 08512, United States.
CMC Management, WuXi Biologics, 1 Cedarbrook Dr, Cranbury, NJ 08512, United States.
Antib Ther. 2025 May 8;8(3):177-188. doi: 10.1093/abt/tbaf009. eCollection 2025 Jul.
In drug development, placebo-controlled trials are vital for assessing treatment efficacy. Developing a suitable placebo for injectable biologics presents unique challenges, particularly in matching the physical characteristics of the active drug without containing its active pharmaceutical ingredient.
Our study developed a methodology for biologic placebo formulations, focusing on color and viscosity matching, in relevant chemical matrixes. A custom color deconvolution algorithm was used for precise color-matching, and sodium carboxymethyl cellulose (Na-CMC) was employed to adjust viscosity in different buffer systems. The interactions between buffers, color agents, and excipients were investigated to ensure consistency in physical properties. Stability testing was conducted under freeze/thaw and thermal stress conditions.
The color-matching algorithm successfully achieved visually indistinguishable results from the active drug, measured by an empirical parameter for color differences (ΔE values). Na-CMC was effective in matching the viscosity of biologic formulations, maintaining the desired physical appearance. Significant interactions between color agents and buffer systems influenced viscosity and osmolality. Stability tests confirmed that the placebo formulations retained their color, pH, and osmolality, with only minor viscosity changes after stress testing.
Our study presents a systematic approach to biologic placebo development, providing a reliable framework for matching the color and viscosity of biologics. The methods and findings support the use of tailored excipients and color-matching algorithms to ensure clinical blinding in trials, enhancing the rigor of drug efficacy assessments and contributing to future placebo design in biologic drug development.
在药物研发中,安慰剂对照试验对于评估治疗效果至关重要。开发适用于注射用生物制品的安慰剂面临独特挑战,尤其是要在不包含活性药物成分的情况下匹配活性药物的物理特性。
我们的研究开发了一种用于生物制品安慰剂配方的方法,重点在于在相关化学基质中进行颜色和粘度匹配。使用定制的颜色反卷积算法进行精确的颜色匹配,并采用羧甲基纤维素钠(Na-CMC)在不同缓冲系统中调节粘度。研究了缓冲液、色素和辅料之间的相互作用,以确保物理性质的一致性。在冻融和热应激条件下进行稳定性测试。
通过颜色差异的经验参数(ΔE值)测量,颜色匹配算法成功实现了与活性药物在视觉上无法区分的结果。Na-CMC有效地匹配了生物制品配方的粘度,保持了所需的物理外观。色素与缓冲系统之间的显著相互作用影响了粘度和渗透压。稳定性测试证实,安慰剂配方保持了其颜色、pH值和渗透压,应激测试后粘度仅有轻微变化。
我们的研究提出了一种系统的生物制品安慰剂开发方法,为匹配生物制品的颜色和粘度提供了可靠的框架。这些方法和研究结果支持使用定制的辅料和颜色匹配算法,以确保试验中的临床盲法,提高药物疗效评估的严谨性,并为生物药物研发中的未来安慰剂设计做出贡献。